485 filings
EFFECT
CYTO
Altamira Therapeutics Ltd
18 Apr 24
Notice of effectiveness
12:15am
424B4
CYTO
Altamira Therapeutics Ltd
17 Apr 24
Prospectus supplement with pricing info
4:20pm
6-K
CYTO
Altamira Therapeutics Ltd
16 Apr 24
Notice of the Annual General Meeting of Shareholders
5:00pm
6-K
CYTO
Altamira Therapeutics Ltd
10 Apr 24
Altamira Therapeutics Provides Business Update, Reports Full Year 2023 Financial Results
8:30am
S-8
CYTO
Altamira Therapeutics Ltd
10 Apr 24
Registration of securities for employees
8:15am
F-1
CYTO
Altamira Therapeutics Ltd
10 Apr 24
Registration statement (foreign)
8:15am
20-F
2023 FY
CYTO
Altamira Therapeutics Ltd
Annual report (foreign)
10 Apr 24
8:00am
SC 13D/A
Meyer Thomas
13 Mar 24
Altamira Therapeutics / Meyer Thomas ownership change
11:03am
424B4
CYTO
Altamira Therapeutics Ltd
22 Jan 24
Prospectus supplement with pricing info
5:02pm
EFFECT
CYTO
Altamira Therapeutics Ltd
22 Jan 24
Notice of effectiveness
12:15am
6-K
CYTO
Altamira Therapeutics Ltd
19 Jan 24
Report of Foreign Private Issuer
4:45pm
424B5
CYTO
Altamira Therapeutics Ltd
19 Jan 24
Prospectus supplement for primary offering
4:40pm
6-K
CYTO
Altamira Therapeutics Ltd
19 Jan 24
Report of Foreign Private Issuer
4:30pm
CORRESP
CYTO
Altamira Therapeutics Ltd
17 Jan 24
Correspondence with SEC
12:00am
UPLOAD
CYTO
Altamira Therapeutics Ltd
16 Jan 24
Letter from SEC
12:00am
F-3
CYTO
Altamira Therapeutics Ltd
8 Jan 24
Shelf registration (foreign)
5:02pm
6-K
CYTO
Altamira Therapeutics Ltd
11 Dec 23
Altamira Therapeutics Provides Investor and Business Update
8:01am
6-K
CYTO
Altamira Therapeutics Ltd
11 Dec 23
Report of Foreign Private Issuer
8:00am
6-K
CYTO
Altamira Therapeutics Ltd
8 Dec 23
Report of Foreign Private Issuer
9:00am
6-K
CYTO
Altamira Therapeutics Ltd
22 Nov 23
Report of Foreign Private Issuer
4:30pm